552 related articles for article (PubMed ID: 29180759)
1. Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression.
Lu J; Liu X; Liao YP; Salazar F; Sun B; Jiang W; Chang CH; Jiang J; Wang X; Wu AM; Meng H; Nel AE
Nat Commun; 2017 Nov; 8(1):1811. PubMed ID: 29180759
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
[TBL] [Abstract][Full Text] [Related]
3. Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy.
Wan Z; Sun J; Xu J; Moharil P; Chen J; Xu J; Zhu J; Li J; Huang Y; Xu P; Ma X; Xie W; Lu B; Li S
Acta Biomater; 2019 May; 90():300-313. PubMed ID: 30930305
[TBL] [Abstract][Full Text] [Related]
4. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
[TBL] [Abstract][Full Text] [Related]
5. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
[TBL] [Abstract][Full Text] [Related]
6. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal.
Mundry CS; Eberle KC; Singh PK; Hollingsworth MA; Mehla K
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188387. PubMed ID: 32579889
[TBL] [Abstract][Full Text] [Related]
8. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
[TBL] [Abstract][Full Text] [Related]
9. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
10. Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-immunotherapy in Multiple Solid Tumors.
Mei KC; Liao YP; Jiang J; Chiang M; Khazaieli M; Liu X; Wang X; Liu Q; Chang CH; Zhang X; Li J; Ji Y; Melano B; Telesca D; Xia T; Meng H; Nel AE
ACS Nano; 2020 Oct; 14(10):13343-13366. PubMed ID: 32940463
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical assembly of hyaluronan coated albumin nanoparticles for pancreatic cancer chemoimmunotherapy.
Hu Y; Chen X; Xu Y; Han X; Wang M; Gong T; Zhang ZR; John Kao W; Fu Y
Nanoscale; 2019 Sep; 11(35):16476-16487. PubMed ID: 31453622
[TBL] [Abstract][Full Text] [Related]
12. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy.
Huang H; Jiang CT; Shen S; Liu A; Gan YJ; Tong QS; Chen SB; Gao ZX; Du JZ; Cao J; Wang J
Nano Lett; 2019 Aug; 19(8):5356-5365. PubMed ID: 31286779
[TBL] [Abstract][Full Text] [Related]
13. Self-controlled release of Oxaliplatin prodrug from d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) functionalized mesoporous silica nanoparticles for cancer therapy.
Liang C; Wang H; Zhang M; Cheng W; Li Z; Nie J; Liu G; Lian D; Xie Z; Huang L; Zeng X
J Colloid Interface Sci; 2018 Sep; 525():1-10. PubMed ID: 29679795
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.
Zhou W; Zhou Y; Chen X; Ning T; Chen H; Guo Q; Zhang Y; Liu P; Zhang Y; Li C; Chu Y; Sun T; Jiang C
Biomaterials; 2021 Jan; 268():120546. PubMed ID: 33253966
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO.
Zhang A; Zheng Y; Que Z; Zhang L; Lin S; Le V; Liu J; Tian J
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1883-90. PubMed ID: 24980548
[TBL] [Abstract][Full Text] [Related]
16. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
17. IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma.
Blair AB; Kleponis J; Thomas DL; Muth ST; Murphy AG; Kim V; Zheng L
J Clin Invest; 2019 Apr; 129(4):1742-1755. PubMed ID: 30747725
[TBL] [Abstract][Full Text] [Related]
18. An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy.
Hu Z; Zheng B; Xu J; Gao S; Lu W
Nanotechnology; 2020 May; 31(29):295101. PubMed ID: 32203949
[TBL] [Abstract][Full Text] [Related]
19. Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ; Prendergast GC
Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
